Searching News Database: Oncothyreon
HSMN NewsFeed - 6 Sep 2013
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
HSMN NewsFeed - 24 Jul 2012
Oncothyreon Appoints Guy Cipriani as Vice President, Business Development
Oncothyreon Appoints Guy Cipriani as Vice President, Business Development
HSMN NewsFeed - 21 Jun 2012
Oncothyreon Announces Promotion of Scott Peterson, Ph.D., to Chief Scientific Officer
Oncothyreon Announces Promotion of Scott Peterson, Ph.D., to Chief Scientific Officer
HSMN NewsFeed - 19 May 2010
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
HSMN NewsFeed - 23 Mar 2010
Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
HSMN NewsFeed - 5 Oct 2009
Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
HSMN NewsFeed - 12 Aug 2009
Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharmaceutical Operations
Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharmaceutical Operations
HSMN NewsFeed - 4 Aug 2009
Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
HSMN NewsFeed - 15 Jun 2009
Oncothyreon appoints Scott Peterson as Vice President of Research and Development
Oncothyreon appoints Scott Peterson as Vice President of Research and Development
HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
HSMN NewsFeed - 13 Aug 2008
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman